Fluence Corporation is pleased to announce that it has signed a Joint Development Agreement (JDA) with Beijing Enterprises Water Group (China) Investment Limited to optimize AspiralTM MABR solution for use in decentralized wastewater treatment applications in China and globally.
“This agreement between Fluence and BEWG aligns with our strategy to collaborate with leaders in the wastewater treatment industry,” said Wong Jin Yong, CEO of Fluence China. “BEWG’s substantial base of wastewater treatment plant operations and market reach offer an excellent channel to market for our MABR products. Our China team is excited to extend our work with BEWG on MABR applications, optimizing these for local market needs, establishing a long-term strategic partnership and contributing to environmental improvement. BEWG has been a key player in the Yangtze river and Yellow river remediation projects which have significant need for decentralized solutions. We are grateful to be working with the technical committee of Ms. Shijun Hang, Chief Consultant & Director of the Technical Committee of BEWG, on this important program.”
Fluence has already sold 281 MABR plants, many of which are operating in China.
As of the end of calendar year 2020, BEWG managed 1,334 plants worldwide including 1,115 wastewater treatment plants and generated US$3.3 billion in revenue. BEWG’s activities include industrial investment, design, construction, operation, technical services and operation of water and wastewater treatment plants. It ranks in the top tier in China’s water industry in terms of total assets, revenue, and water treatment capacity.
BEWG (Stock Code: HK00371), is listed on the main board of the Stock Exchange of Hong Kong Limited, has been selected as a constituent stock of Hong Kong's Hang Seng China-affiliated Corporations Index, Morgan Stanley Capital International Index and other major international indexes.
